MetaCap

Electra Therapeutics (ETRA) vs Sana Biotechnology (SANA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Electra Therapeutics is the larger company by market cap ($509.8 million vs $476.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETRA-38.79%SANA-48.71%
+10%-21%-52%
Sep 18, 20261 yearNov 20, 2026
ETRA-38.79%SANA-48.71%
+2%-24%-51%
Sep 14, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETRA versus SANA key metrics
MetricETRASANA
Share price$8.11$1.59
Market cap$509.85M$476.42M
1-day change-9.28%-8.62%
YTD return—-60.93%
1-year return—-51.67%
5-year return—-91.34%
EPS (TTM)$-35.94$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-244.17M
52-week high$15.50$5.49
52-week low$6.87$1.57
Distance from 52-week high-47.68%-71.04%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+309.37%+438.99%
Average volume559.28K3.30M
Shares outstanding62.87M299.63M
Employees46142
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Electra Therapeutics

ETRA stock →

Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees

About Sana Biotechnology

SANA stock →

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 142 employees

ETRA vs SANA FAQ

Which is bigger, Electra Therapeutics or Sana Biotechnology?

Electra Therapeutics (ETRA) is larger, with a market capitalization of $509.85M compared with $476.42M for Sana Biotechnology (SANA).

Are Electra Therapeutics and Sana Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons